Nathan Buchbinder (@nate_buchbinder) 's Twitter Profile
Nathan Buchbinder

@nate_buchbinder

AI Thought Leader and Forbes 30 Under 30
Cofounder and Chief Product Officer

ID: 400960536

linkhttps://Proscia.com calendar_today29-10-2011 20:54:15

98 Tweet

192 Takipçi

618 Takip Edilen

Scott Gottlieb, MD 🇺🇸 (@scottgottliebmd) 's Twitter Profile Photo

My essay in JAMA today on targeted reforms that U.S. FDA could make to help facilitate the adoption of AI to high value clinical applications inside electronic medical records — to improve physician precision and productivity, and patient outcomes jamanetwork.com/journals/jama-…

Julianna Ianni (@juliannalog) 's Twitter Profile Photo

Exciting times at Proscia! Our recent funding will propel AI innovation in pathology, enhancing precision medicine & diagnostics. Looking forward to accelerating breakthroughs, expanding the possibilities of AI, & transforming the future of healthcare!

Proscia (@proscia) 's Twitter Profile Photo

Introducing our inaugural Proscia awardees! We are fortunate to have so many #digitalpathology leaders as part of the Concentriq community. What better opportunity to recognize some of our customers' most notable accomplishments than at #USCAP2025? 🧵

Introducing our inaugural Proscia awardees!

We are fortunate to have so many #digitalpathology leaders as part of the Concentriq community.

What better opportunity to recognize some of our customers' most notable accomplishments than at #USCAP2025? 🧵
Proscia (@proscia) 's Twitter Profile Photo

According to CSO Nathan Buchbinder, the future of medicine is going to come from combining our deep understanding of genomic insights w/ the messy reality of human phenotypes, & it’s at this intersection where the real breakthroughs begin. Hear his full take below.

Proscia (@proscia) 's Twitter Profile Photo

See the digital pathology platform trusted by the pharma companies behind 34 of the top 50 best-selling drugs. Get a live demo of Concentriq LS from our team at booth 3239 during #AACR25. AACR

See the digital pathology platform trusted by the pharma companies behind 34 of the top 50 best-selling drugs. 

Get a live demo of Concentriq LS from our team at booth 3239 during #AACR25.

<a href="/AACR/">AACR</a>
CellNetix (@cellnetixlabs) 's Twitter Profile Photo

Dr. Dominique Coco co-presented at USCAP's Annual Meeting last month in a seminar that provided insights on how digital pathology solutions can be effectively utilized to deliver optimal lab efficiency and clinical utility. Learn more: tinyurl.com/mrxv9cp9

Dr. Dominique Coco co-presented at USCAP's Annual Meeting last month in a seminar that provided insights on how digital pathology solutions can be effectively utilized to deliver optimal lab efficiency and clinical utility. Learn more: tinyurl.com/mrxv9cp9
Proscia (@proscia) 's Twitter Profile Photo

Build a zero-shot tissue classification model in minutes, no annotated data needed. Watch as our Senior AI Scientist uses Concentriq Embeddings & PLIP, a multimodal vision-language FM, to generate slide-level predictions & heatmaps that visually highlight tumor regions below.

Tim Bracey (@drtimbracey) 's Twitter Profile Photo

The NHS need to create a national, cloud based digital pathology system to allow outsourcing and expert second opinions, preventing local silos that would otherwise require already digitised glass slides being sent away. Read more at the following link... pathkids.com/wp/2025/05/09/…

The NHS need to create a national, cloud based digital pathology system to allow outsourcing and expert second opinions, preventing local silos that would otherwise require already digitised glass slides being sent away.
Read more at the following link...
pathkids.com/wp/2025/05/09/…
Proscia (@proscia) 's Twitter Profile Photo

The Pathologist IQVIA Plus, our own Chief Strategy Officer, Nathan Buchbinder, explains why molecular and pathology data must work together to drive precision medicine. thepathologist.com/issues/2025/ar…

Denis Wirtz (@deniswirtz) 's Twitter Profile Photo

We introduce InterpolAI, an optical flow-based AI model to enhance 3D imaging (MRI, CODA, ssTEM, light sheet) Read about it here in our new NM paper: nature.com/articles/s4159…

Proscia (@proscia) 's Twitter Profile Photo

Our AI scientist built a zero-shot tissue classification model in minutes using Concentriq Embeddings & PLIP, a multimodal vision-language foundation model. No annotated training data needed. And during our pre-conference workshop, you’ll learn how to do it yourself in <2 hrs.

Our AI scientist built a zero-shot tissue classification model in minutes using Concentriq Embeddings &amp; PLIP, a multimodal vision-language foundation model. No annotated training data needed.

And during our pre-conference workshop, you’ll learn how to do it yourself in &lt;2 hrs.
Proscia (@proscia) 's Twitter Profile Photo

.Labcorp just announced the expansion of its oncology portfolio to improve patient care and advance cancer research. As part of this initiative, it's using Concentriq LS across its global central labs to accelerate clinical trials. 👏 labcorp.com/education-even…

.<a href="/Labcorp/">Labcorp</a> just announced the expansion of its oncology portfolio to improve patient care and advance cancer research.  

As part of this initiative, it's using Concentriq LS across its global central labs to accelerate clinical trials. 👏

labcorp.com/education-even…
Nathan Buchbinder (@nate_buchbinder) 's Twitter Profile Photo

DICOM continues to see more and more traction in pathology. My thoughts on how this new reality is shaping out and why it's so impactful:

ASCP (@ascp_chicago) 's Twitter Profile Photo

The FDA chose not to appeal the court decision that struck its attempt to regulate LDTs. The court made it clear: oversight of LDTs belongs to CMS under CLIA, not the FDA—exactly what ASCP has long advocated. ASCP will keep working with CMS and pushing back against efforts like

U.S. FDA (@us_fda) 's Twitter Profile Photo

Today, the FDA launched Elsa, a generative AI tool designed to help employees—from scientific reviewers to investigators—work more efficiently. This innovative tool modernizes agency functions and leverages AI capabilities to better serve the American people. Elsa in Action ➤

Proscia (@proscia) 's Twitter Profile Photo

At the #DigitalPathology & AI Congress, we guided scientists, lab leaders, and pathologists through the dev of an AI app in <2 hrs using Concentriq Embeddings. Here are some key insights from our hands-on session. 👇 •Successful AI in pathology doesn't start w/ complex

At the #DigitalPathology &amp; AI Congress, we guided scientists, lab leaders, and pathologists through the dev of an AI app in &lt;2 hrs using Concentriq Embeddings. 

Here are some key insights from our hands-on session. 👇

•Successful AI in pathology doesn't start w/ complex
Proscia (@proscia) 's Twitter Profile Photo

New research confirms it: Diagnostic lab leaders see #digitalpathology & AI as critical to advancing #precisionmedicine. The 2025 Laboratory Leadership Report, a survey of 360 lab professionals conducted by The Dark Report on our behalf, has the details. Check it out here.

Nathan Buchbinder (@nate_buchbinder) 's Twitter Profile Photo

In a Cleveland Clinic study from Dr. Christopher Weight, AI was able to accurately identify 15 out of 16 high-risk metastatic patients using digital pathology. Incredible work from their team and a testament to the power of computational pathology in precision medicine.

Proscia (@proscia) 's Twitter Profile Photo

CTO Coleman Stavish shares more about the Connectathon in our latest blog: proscia.com/proscia-demons… You can also visit our team at booth 49 to learn more about how Proscia is helping leading laboratories to capitalize on DICOM, AI, and more.